Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Curious about easy ways to earn quickly? Discover the simplest methods to make money fast and start boosting your income today.
18,749 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A prominent crypto trader files a lawsuit against Coinbase claiming it refused to return DAI funds stolen in a phishi...
A new class-action settlement over Apple’s advertising claims could put money back in the hands of iPhone buyers. The...
A bizarre online listing claims a desk art piece tied to Epstein. This article explores the business case, ethics, an...
Imagine starting with a $10,000 Alphabet Right Now investment and letting time compound. This article walks you throu...
Investors flooded crypto funds with $858M in inflows as lawmakers push a clarity-focused framework for stablecoins. T...
Institutional investors are pouring money back into XRP ETFs, driving inflows to a five-month high. Analysts say this...
Ethereum is the lone red stake among the top-10 cryptos this week, while Bitcoin and other large caps post gains as i...
XRP on-chain activity climbs to a fresh milestone as big holders stock up, even as the price slips under $1.45. The m...
XRP climbs toward a fresh high while a handful of large holders tighten their grip on the supply. Regulatory headline...
A prominent institutional investor revealed a sizable Callaway Golf stake as the stock surged. This article breaks do...
Traders are watching Ripple’s payments push and regulatory tones as an AI model’s no-guardrails forecast for XRP by 2...